Side-by-side comparison of AI visibility scores, market position, and capabilities
Cogsy is an inventory planning and demand forecasting platform for DTC e-commerce brands, based in San Francisco.
Cogsy was founded in San Francisco to solve one of the most persistent operational challenges for growing DTC e-commerce brands: inventory planning. Most DTC brands manage purchasing decisions through spreadsheets and gut feel until they reach a scale where the costs of overstocking and stockouts become significant enough to justify dedicated planning tooling. Cogsy was built to bridge that gap, providing algorithmic demand forecasting and purchase order management for DTC brands that have outgrown spreadsheets but are not ready for enterprise supply chain planning systems.\n\nThe Cogsy platform connects to Shopify and other e-commerce platforms to ingest historical sales data and uses that data to generate demand forecasts at the SKU level, factoring in seasonality, growth trends, and marketing calendar inputs. The platform translates those forecasts into purchase order recommendations that give buying teams a starting point for reorder decisions, with the ability to adjust for qualitative factors like planned promotions or expected launch performance. Cogsy also provides inventory health analytics that surface at-risk stockout items and excess inventory positions before they become operational or financial problems.\n\nCogsy targets DTC e-commerce brands in the $2M to $50M annual revenue range that have complex enough SKU counts and supply chain lead times to make systematic demand planning valuable, but are too small to justify enterprise planning implementations. The company competes against Inventory Planner, Skubana, and Brightpearl in the DTC inventory planning space, differentiating through its demand forecasting sophistication and its UX designed for DTC operators rather than supply chain professionals.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.